UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab

Alimentary pharmacology & therapeutics, 2019-01, Vol.49 (1), p.31-40

2019

Volltextzugriff (PDF)

Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis

JAMA internal medicine, 2013-08, Vol.173 (15), p.1416

2013

Volltextzugriff (PDF)

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.1177-1189

2019

Volltextzugriff (PDF)

Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan

PloS one, 2020-12, Vol.15 (12), p.e0244620

2020

Volltextzugriff (PDF)

Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis

British journal of dermatology (1951), 2017-03, Vol.176 (3), p.594-603

2017

Volltextzugriff (PDF)

A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry

Rheumatology (Oxford, England), 2020-10, Vol.59 (10), p.2796-2805

2020

Volltextzugriff (PDF)

The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases

American journal of clinical dermatology, 2024-07, Vol.25 (4), p.595-607

2024

Volltextzugriff (PDF)

To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis

Journal of the American Academy of Dermatology, 2015-09, Vol.73 (3), p.420-428.e1

2015

Volltextzugriff (PDF)

Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses

United European Gastroenterology Journal, 2019-12, Vol.7 (10), p.1285-1303

2019

Volltextzugriff (PDF)

Efficacy and safety of biological agents in adult-onset Still's disease

Scandinavian journal of rheumatology, 2015-07, Vol.44 (4), p.309-314

2015

Volltextzugriff (PDF)

Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update

Expert review of clinical pharmacology, 2021-02, Vol.14 (2), p.179-210

2021

Volltextzugriff (PDF)

Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials

International journal of clinical pharmacology and therapeutics, 2022-01, Vol.60 (1), p.13-23

2022

Volltextzugriff (PDF)

Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patients

British journal of dermatology (1951), 2014-09, Vol.171 (3), p.485-491

2014

Volltextzugriff (PDF)

Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials

Medicine (Baltimore), 2020-07, Vol.99 (31), p.e21447

2020

Volltextzugriff (PDF)

nab -Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Cancer treatment reviews, 2014-06, Vol.40 (5), p.614-625

2014

Volltextzugriff (PDF)

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

Journal of managed care & specialty pharmacy, 2020-04, Vol.26 (4), p.417-490

2020

Volltextzugriff (PDF)

Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review

International journal of dermatology, 2020-05, Vol.59 (5), p.520-524

2020

Volltextzugriff (PDF)

IBD in 2013: enriching the therapeutic armamentarium for IBD

Nature reviews. Gastroenterology & hepatology, 2014-02, Vol.11 (2), p.84

2014

Volltextzugriff (PDF)

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison

The European journal of health economics, 2014-05, Vol.15 (Suppl 1), p.S53-S64

2014

Volltextzugriff (PDF)

Expanded Table: Some biologic drugs and JAK inhibitors for rheumatoid arthritis

The Medical letter on drugs and therapeutics (English ed.), 2021-11, Vol.63 (1637), p.e187-e189

2021

Volltextzugriff (PDF)

The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review

Rhode Island medical journal (2013), 2016-06, Vol.99 (6), p.26-29

2016

Volltextzugriff (PDF)

Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach

World journal of gastroenterology : WJG, 2008-05, Vol.14 (17), p.2670-2677

2008

Volltextzugriff (PDF)

Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry

Actas dermo-sifiliográficas (English ed.), 2017-01, Vol.108 (1), p.52-58

2017

Volltextzugriff (PDF)

Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease

Actas dermo-sifiliográficas (English ed.), 2016-09, Vol.107 Suppl 2, p.43-50

2016

Volltextzugriff (PDF)

Safety of Conventional Systemic Agents and Biologic Agents in the Treatment of Psoriasis

Journal of cutaneous medicine and surgery, 2009-09, Vol.13 (5_suppl), p.S67-S76

2009

Volltextzugriff (PDF)

1 – 25 von 15.690

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15.086)
Mit Volltextzugriff
(12.706)

Publikationsform

Artikel
(15.689)
Tagungsberichte
(1)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(15.543)
Science & Technology
(14.961)
Life Sciences & Biomedicine
(14.939)
Biological And Medical Sciences
(14.618)
Medical Sciences
(14.538)
Female
(12.467)
Male
(12.115)
Middle Aged
(10.203)
Time Factors
(8.436)
Aged
(8.220)
Adult
(7.905)
Risk Factors
(6.160)
Surgery
(4.529)
Retrospective Studies
(4.196)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(3.893)
Cardiovascular System & Cardiology
(3.496)
Pharmacology. Drug Treatments
(3.473)
Aged, 80 And Over
(3.139)
Risk Assessment
(3.067)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(15.688)
Journals@Ovid Complete
(9.950)
Ingenta
(9.281)
EZB Free E-Journals
(7.284)
Single Journals
(5.283)
ScienceDirect Pay Per View(PPV) Titles
(4.776)
IngentaConnect Journals
(3.589)
Wiley Online Library Journals Frontfile Complete
(2.005)
Wiley Online Library Full Collection 2018
(1.648)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.581)
SpringerLink Journals - AutoHoldings
(1.490)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.200)
Oxford journals
(722)
Nature
(579)
SAGE Premier Complete
(562)
Oxford Journals 2020 Medicine
(551)
Nexis Uni
(453)
BMJ Journals
(334)
Taylor & Francis Journals Auto-Holdings Collection
(326)
BMJ Journals Archiv - DFG Nationallizenzen
(299)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab

Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis

Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study

Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan

Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis

A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry

The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases

To test or not to test? An updated evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis and psoriatic arthritis

Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses

Efficacy and safety of biological agents in adult-onset Still's disease

Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update

Comparative efficacy and safety of biologic agents in patients with active rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitors: A Bayesian network meta-analysis of randomized controlled trials

Safety of biological therapies for psoriasis: effects on reproductive potential and outcomes in male and female patients

Fourteen small molecule and biological agents for psoriatic arthritis: A network meta-analysis of randomized controlled trials

nab -Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review

IBD in 2013: enriching the therapeutic armamentarium for IBD

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison

Expanded Table: Some biologic drugs and JAK inhibitors for rheumatoid arthritis

The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review

Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach

Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry

Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease

Safety of Conventional Systemic Agents and Biologic Agents in the Treatment of Psoriasis

Aktive Filter

Suchergebnisse filtern